Exact Sciences Schedules First Quarter 2025 Earnings Call
Exact Sciences (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, has scheduled its first quarter 2025 earnings release for May 1, 2025, after U.S. market close. The company will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
The live webcast will be accessible through www.exactsciences.com. Domestic callers can dial 888-330-2384, while international callers should use +1 240-789-2701. Both domestic and international callers will need to use access code 4437608. A replay of the webcast will be made available on the company's website.
Exact Sciences (Nasdaq: EXAS), un fornitore leader di test di screening e diagnostici per il cancro, ha programmato il suo rilascio dei risultati finanziari del primo trimestre 2025 per il 1° maggio 2025, dopo la chiusura del mercato statunitense. L'azienda ospiterà un webcast e una conferenza telefonica alle 17:00 ET per discutere i risultati finanziari e i progressi aziendali.
Il webcast in diretta sarà accessibile attraverso www.exactsciences.com. I chiamanti nazionali possono comporre il numero 888-330-2384, mentre i chiamanti internazionali dovrebbero utilizzare il numero +1 240-789-2701. Sia i chiamanti nazionali che internazionali dovranno utilizzare il codice di accesso 4437608. Una registrazione del webcast sarà disponibile sul sito web dell'azienda.
Exact Sciences (Nasdaq: EXAS), un proveedor líder de pruebas de detección y diagnóstico de cáncer, ha programado su publicación de resultados del primer trimestre de 2025 para el 1 de mayo de 2025, después del cierre del mercado estadounidense. La compañía llevará a cabo un webcast y una llamada de conferencia a las 5 p.m. ET para discutir los resultados financieros y el progreso empresarial.
El webcast en vivo será accesible a través de www.exactsciences.com. Los llamadores nacionales pueden marcar el 888-330-2384, mientras que los llamadores internacionales deben usar el +1 240-789-2701. Tanto los llamadores nacionales como internacionales deberán usar el código de acceso 4437608. Se pondrá a disposición una repetición del webcast en el sitio web de la empresa.
Exact Sciences (Nasdaq: EXAS)는 암 검사 및 진단 테스트의 선도적인 제공업체로서, 2025년 1분기 실적 발표를 2025년 5월 1일 미국 시장 마감 후에 예정하고 있습니다. 회사는 오후 5시 ET에 재무 결과 및 사업 진행 상황에 대해 논의하기 위해 웹캐스트와 컨퍼런스 콜을 개최할 것입니다.
실시간 웹캐스트는 www.exactsciences.com을 통해 접근할 수 있습니다. 국내 전화는 888-330-2384로, 국제 전화는 +1 240-789-2701을 사용해야 합니다. 국내 및 국제 전화 모두 4437608 접근 코드를 사용해야 합니다. 웹캐스트의 재생은 회사 웹사이트에서 제공될 것입니다.
Exact Sciences (Nasdaq: EXAS), un fournisseur leader de tests de dépistage et de diagnostic du cancer, a programmé la publication de ses résultats du premier trimestre 2025 pour le 1er mai 2025, après la fermeture du marché américain. L'entreprise organisera un webcast et une conférence téléphonique à 17h00 ET pour discuter des résultats financiers et des avancées de l'entreprise.
Le webcast en direct sera accessible via www.exactsciences.com. Les appelants nationaux peuvent composer le 888-330-2384, tandis que les appelants internationaux doivent utiliser le +1 240-789-2701. Les appelants nationaux et internationaux devront utiliser le code d'accès 4437608. Un enregistrement du webcast sera disponible sur le site web de l'entreprise.
Exact Sciences (Nasdaq: EXAS), ein führender Anbieter von Krebs-Screening- und Diagnosetests, hat die Veröffentlichung der Ergebnisse für das erste Quartal 2025 für den 1. Mai 2025, nach Börsenschluss in den USA, angesetzt. Das Unternehmen wird um 17:00 Uhr ET ein Webcast und eine Telefonkonferenz veranstalten, um die finanziellen Ergebnisse und den Fortschritt des Unternehmens zu besprechen.
Der Live-Webcast wird über www.exactsciences.com zugänglich sein. Inlandsanrufer können die Nummer 888-330-2384 wählen, während internationale Anrufer +1 240-789-2701 verwenden sollten. Sowohl nationale als auch internationale Anrufer müssen den Zugangscode 4437608 verwenden. Eine Wiederholung des Webcasts wird auf der Unternehmenswebsite zur Verfügung stehen.
- None.
- None.
First quarter 2025 webcast & conference call details
Date: |
Thursday, May 1, 2025 |
|
Time: |
5 p.m. ET |
|
Webcast: |
The live webcast can be accessed at www.exactsciences.com |
|
Telephone: |
Domestic callers, dial 888-330-2384
Access code for both domestic and international callers: 4437608 |
A replay of the webcast will be available at www.exactsciences.com. The webcast, conference call, and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401524918/en/
Derek Leckow
Exact Sciences Corp.
investorrelations@exactsciences.com
608-893-0009
Source: Exact Sciences Corp.
FAQ
When will Exact Sciences (EXAS) release Q1 2025 earnings?
How can investors join Exact Sciences' (EXAS) Q1 2025 earnings call?
What time is Exact Sciences' (EXAS) Q1 2025 earnings call?
Will there be a replay available for Exact Sciences' (EXAS) Q1 2025 earnings call?
